SINTX Technologies Announces Closing of $4.0 Million Public Offering
Summary
Ascendiant Capital Markets LLC acted as the Companys financial advisor.The securities described above were offered pursuant to a registration statement on Form S-1, as amended (File No. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. The Company has manufacturing facilities in Utah and Maryland.For more information on SINTX Technologies or its silicon nitride material platform, please visit .This press release contains forward-looking statements, including those relating to the offering, within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect managements current estimates, projections, expectations, and beliefs. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.